Earn up to 2 CME/CE credits

FOCUS ON PSYCHOTIC AND MOOD DISORDERS

We are pleased to invite you to the Psychiatry Update: Focus on Psychotic and Mood Disorders, a virtual CME meeting with renowned faculty and informative presentations on schizophrenia, MDD, and bipolar disorder, as well as innovative treatments and how to implement them into practice.

Our interactive conference center makes participating in the live virtual sessions and Q&As easy. We know that connecting with colleagues is crucial; our forums make it seamless to network, share ideas, and catch up with colleagues around the world.

All of this is in service of what matters most – taking home the kind of breakthroughs that can make a difference in your patients’ lives. This is a one-of-a-kind experience for the psychiatry community that you won’t want to miss - a taste of our annual Psychiatry Update, which returns in March 2025!

Register today for this innovative event! We look forward to you joining us on November 12, 2024!

NON-CME/CE BONUS PRESENTATION

7:00 pm — 8:00 pm
A Clear Choice for Plaque Psoriasis Topical Treatment
This is a Non-CME/CE Presentation
Mona Shahriari, MD, FAAD
Learn about a once-daily, topical treatment without steroids! We’ll explore the clinical safety and efficacy data and how this treatment could fit into your practice.
Sponsored By Arcutis
Arcutis Company Logo

SPEAKER

Mona Shahriari, MD, FAAD

AGENDA

6:00 pm — 7:00 pm
Non-CME/CE Bonus Presentation
7:00 pm — 8:00 pm
Psychotic Disorders
Christoph U. Correll, MD; Diana Perkins, MD, MPH
Introduction
Schizophrenia: Pathophysiology and Current Treatment Regimen
Schizophrenia: Novel New Treatments: and How to Implement Them Into Practice
Audience Q&A and Panel Discussion
8:00 pm — 9:00 pm
Non-CME/CE Bonus Presentation
9:00 pm — 10:00 pm
Mood Disorders
Leslie Citrome, MD, MPH; Joseph F. Goldberg, MD
Introduction
MDD
Bipolar Disorder
Audience Q&A and Panel Discussion

FACULTY

Joseph Goldberg, MD
Diana Perkins, MD, MPH

REGISTRATION

Standard Rate: $50

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

TARGET AUDIENCE

This conference is designed for psychiatrists, neurologists, primary care physicians, nurse practitioners, nurses, physician assistants, pharmacists, and other healthcare professionals who provide care to patients with psychiatric conditions.

LEARNING OBJECTIVES

As a result of participating in this live activity, participants should be able to:

  • Describe innovations in pharmacotherapy for the treatment of schizophrenia.
  • Demonstrate competence in their ability to identify and diagnose mood disorders.

JOINT ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Academy for Medical Education. Postgraduate Institute for Medicine is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 2.0 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on certificates.
Credit amount subject to change